Warnex Medical Laboratories
In Brief This Week: Luminex; Life Technologies; CombiMatrix; Danaher; Biotrial, Warnex; Almac
NEW YORK (GenomeWeb News) – Luminex's board of directors has authorized the firm to repurchase up to the lesser of $22.5 million worth or 900,000 shares of the company's outstanding common stock. The repurchase program is scheduled to expire Dec.
Warnex Sells Bioanalytical Business to Biotrial; Active Operations Winding Down
NEW YORK (GenomeWeb News) – Warnex announced today a binding agreement to sell its Bioanalytical Services division to contract research organization Biotrial Research for C$6 million (US$6 million).
Warnex Inks New Credit Facility with Persistence Capital
NEW YORK (GenomeWeb News) – Warnex today said that it has signed a new credit facility with Persistence Capital Partners, replacing an existing credit facility with Accord Financial.
Warnex Completes Sale of Analytical Services Division to Neopharm
NEW YORK (GenomeWeb News) – Warnex today announced it has completed the sale of its Analytical Services division to Neopharm Labs.
Persistence Capital to Hold Majority Stake in Warnex
NEW YORK (GenomeWeb News) – Warnex said this week that the conversion of debentures into shares of the company will provide Persistence Capital Partners with a nearly 52 percent stake in the firm.
Dec 20, 2011
Warnex to Sell Analytical Services Division
Dec 12, 2011
Warnex Sells Medical, Forensics Testing Business
Dec 13, 2010
Warnex Receives Funding for 'Touch DNA' Analysis
Dec 9, 2010
Dec 8, 2010
New Releases: Dec 8, 2010
Premium
Mar 2, 2010
Warnex Lab Accreditation Renewed
Sep 10, 2009
Warnex Signs Up Quebec Distributor for H1N1 Test
Sep 10, 2009
Aug 13, 2009